Summit Therapeutics (SMMT) Reports Q1 Loss of GBP0.09/Share
Tweet
Share
E-mailGet Alerts SMMT Hot Sheet
Join SI Premium – FREE
Summit Therapeutics (NASDAQ: SMMT) reported Q1 EPS of (GBP0.09), versus (GBP0.06) reported last year.
For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c
- Pelthos Therapeutics Inc. (PTHS) Misses Q2 EPS by 611c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
